Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Ischaemia-reperfusion
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatIschaemia-reperfusionOther / unspecifiedWistarMalen = 36 male Wistar rats allocated to 6 groups; statistical comp…Injection via an indwelling right femoral vein catheter used for drug and fluid administration10 micrograms per rat10 minutes prior to reperfusion, that is during the 90-minute ischaemic period
Model: Left lung hilum clamped for 90 minutes of ischaemia followed by 4 hours of reperfusion, in normal rats and in rats with type 2 diabetes induced by 4 weeks of high fat diet plus streptozotocin 35 mg/kg intraperitoneally (fasting plasma glucose at least 11.1 mmol/l)
Type 2 diabetes exacerbated lung ischaemia-reperfusion injury, with higher IL-6, TNF-alpha, wet to dry ratio, lung injury score, oxidative stress and apoptosis and lower oxygenation than normal rats. Globular adiponectin given 10 minutes before reperfusion improved oxygenation and reduced oedema, l…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.